Identification of a novel splice variant for mouse and human interleukin-5.

Alternative splicing Biomolecules Cytokine Gene expression Genetics Immunology Lymphocytes Protein expression

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 30 04 2019
revised: 25 07 2019
accepted: 10 03 2020
entrez: 27 3 2020
pubmed: 27 3 2020
medline: 27 3 2020
Statut: epublish

Résumé

Expression of interleukins and their receptors is often regulated by alternative splicing. Alternative isoform of IL-5 receptor α-chain is well studied; however, no data on functional alternative splice variants of IL-5 has been reported up today. In the present study, we describe a novel splice variant for the mouse and human IL-5. The new form was found during analysis of PCR-products amplified from different mouse lymphoid tissues with a pair of primers designed to clone full-length mIL-5 ORF. A single short isoform of mIL-5 was detected along with the canonical full-length mRNA in ConA-stimulated lymphoid cells isolated from spleen, thymus, lymph nodes and blood. It was 30-40 nt shorter, and less abundant than classical form. The sequence analysis of an additional form of mIL-5 revealed that it lacks exon-2 (δ2). Using RT-PCR with the splice-specific primers we obtained an additional evidence for δ2 form expression. To verify whether mIL-5δ2 transcript is translated into protein, the coding sequences corresponding to full and δ2 forms of mIL-5 were cloned into an expression plasmid. After transfection into the human 293T cell line, we found that the short form of mIL-5 protein is expressed in cells and secreted into the supernatant, but at the reduced level than that detected for full isoform of mIL-5. Fluorescence microscopy examination revealed a partial translocation of mIL-5δ2 into cytoplasm, whereas mIL-5 resided mostly within endoplasmic reticulum. This can explain why the level of δ2 protein expression was reduced. Using a similar set of experimental approaches, we received the evidence that the human IL-5 mRNA has the δ2 splice form (hIL-5δ2) as well. It can be firmly detected by RT-PCR in PHA-activated mononuclear cells isolated from peripheral blood of healthy persons or patients with asthma. Altogether, our results showed that the human and mouse IL-5 have an alternative mRNA splice isoform, which loses exon-2, but nevertheless is expressed at protein level. However, more comprehensive studies will be required for evaluation of IL-5δ2 expression, regulation, biological function and clinical significance.

Identifiants

pubmed: 32211550
doi: 10.1016/j.heliyon.2020.e03586
pii: S2405-8440(20)30431-X
pii: e03586
pmc: PMC7082524
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e03586

Informations de copyright

© 2020 The Author(s).

Références

Cytokine. 2012 Apr;58(1):20-6
pubmed: 22249152
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7388-92
pubmed: 2823259
Growth Factors. 1988;1(1):51-7
pubmed: 3078564
Am J Respir Crit Care Med. 2001 Sep 15;164(6):1016-8
pubmed: 11587989
J Leukoc Biol. 2011 May;89(5):763-70
pubmed: 21285395
J Biol Chem. 1987 Dec 5;262(34):16580-4
pubmed: 2824500
Protein Sci. 2012 Jun;21(6):850-64
pubmed: 22528658
J Exp Med. 1985 Jul 1;162(1):60-74
pubmed: 3925072
J Exp Med. 1996 Jan 1;183(1):195-201
pubmed: 8551223
Nature. 1993 May 13;363(6425):172-6
pubmed: 8483502
Life Sci. 1997;61(12):1105-12
pubmed: 9315502
J Biol Chem. 2008 Oct 24;283(43):28860-72
pubmed: 18708357
Nat Chem Biol. 2009 Nov;5(11):815-22
pubmed: 19841631
EMBO J. 1991 May;10(5):1193-9
pubmed: 2022187
J Allergy Clin Immunol. 1999 Nov;104(5):978-82
pubmed: 10550742
Am J Respir Crit Care Med. 1995 May;151(5):1346-53
pubmed: 7537586
Cell Immunol. 1999 Feb 1;191(2):161-7
pubmed: 9973539
Mem Inst Oswaldo Cruz. 1997;92 Suppl 2:75-91
pubmed: 9698919
Front Med (Lausanne). 2017 Aug 31;4:135
pubmed: 28913336
J Immunol. 1996 Jan 15;156(2):435-41
pubmed: 8543791
Blood. 1992 Jun 15;79(12):3101-9
pubmed: 1596561
Nihon Rinsho. 1995 Mar;53 Su Pt 2:786-9
pubmed: 8753359
J Exp Med. 1982 Mar 1;155(3):914-23
pubmed: 6977612
Exp Hematol. 1991 Oct;19(9):882-7
pubmed: 1893964
J Proteome Res. 2003 May-Jun;2(3):273-81
pubmed: 12814267
J Allergy Clin Immunol. 1993 Aug;92(2):313-24
pubmed: 8349942
Allergy. 1993;48(17 Suppl):98-106; discussion 110-1
pubmed: 8109721
Cytokine. 2017 Nov;99:154-162
pubmed: 28917204
PLoS Pathog. 2010 Feb 26;6(2):e1000788
pubmed: 20195464
EMBO J. 1990 Dec;9(13):4367-74
pubmed: 2265612
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7041-5
pubmed: 1495999
Nucleic Acids Res. 1986 Nov 25;14(22):9149-58
pubmed: 3024129
Proc Natl Acad Sci U S A. 1987 Oct;84(19):6629-33
pubmed: 3498940
Nature. 1986 Nov 6-12;324(6092):70-3
pubmed: 3024009
Expert Rev Clin Immunol. 2016 Sep;12(9):903-5
pubmed: 27450970
Nat New Biol. 1972 May 3;237(70):15-7
pubmed: 4503682
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2311-5
pubmed: 2784567

Auteurs

Igor Shilovskiy (I)

Laboratory of Antiviral Immunity, National Research Center Institute of Immunology of Federal Medico-biological Agency, Kashirskoe shosse 24, Moscow, 115522, Russia.

Sergei Andreev (S)

Laboratory of Peptide Immunogens, National Research Center Institute of Immunology of Federal Medico-biological Agency, Kashirskoe shosse 24, Moscow, 115522, Russia.

Dmitriy Mazurov (D)

Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, Vavilova Street 34/5, Moscow, 119334, Russia.
Laboratory of Immunochemistry, National Research Center Institute of Immunology of Federal Medico-biological Agency, Kashirskoe shosse 24, Moscow, 115522, Russia.

Ekaterina Barvinskaia (E)

Laboratory of Antiviral Immunity, National Research Center Institute of Immunology of Federal Medico-biological Agency, Kashirskoe shosse 24, Moscow, 115522, Russia.

Svetlana Bolotova (S)

Laboratory of Antiviral Immunity, National Research Center Institute of Immunology of Federal Medico-biological Agency, Kashirskoe shosse 24, Moscow, 115522, Russia.

Alexander Nikolskii (A)

Laboratory of Antiviral Immunity, National Research Center Institute of Immunology of Federal Medico-biological Agency, Kashirskoe shosse 24, Moscow, 115522, Russia.

Ilya Sergeev (I)

Laboratory of Human Histocompatibility Genetics, National Research Center Institute of Immunology of Federal Medico-biological Agency, Kashirskoe shosse 24, Moscow, 115522, Russia.

Artem Maerle (A)

Laboratory of Human Histocompatibility Genetics, National Research Center Institute of Immunology of Federal Medico-biological Agency, Kashirskoe shosse 24, Moscow, 115522, Russia.

Dmitrii Kudlay (D)

Laboratory of Personalized Medicine and Molecular Immunology, National Research Center Institute of Immunology of Federal Medico-biological Agency, Kashirskoe shosse 24, Moscow, 115522, Russia.

Musa Khaitov (M)

Laboratory of Personalized Medicine and Molecular Immunology, National Research Center Institute of Immunology of Federal Medico-biological Agency, Kashirskoe shosse 24, Moscow, 115522, Russia.

Classifications MeSH